Original Source(s)
Related Content
Curbing Drug-Related Halitosis for Closer Moments
Individuals who have drug-related halitosis may need to take additional steps to prioritize oral health before intimate encounters.
February 12, 2026
-
3 min
FDA Approves Secukinumab for Adolescents With Moderate to Severe Hidradenitis Suppurativa
Secukinumab becomes the only interleukin-17A inhibitor approved for pediatric patients aged 12 years and older with moderate to severe hidradenitis suppurativa.
March 13, 2026
-
2 min